SynthesisHepatology international2020

Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis.

Quan Rao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.